// App-Quantinova.ai

: HZ-R061, a Selective STAT3 Degrader with Activity in Preclinical Model of Hematologic Malignances

Researchers

Presenter

  • Yizhe WU

Principal Investigators

  • Xingguo Liu

  • Xinxin Jin

  • Jiangfeng Xie

  • Haiyan Yang

  • Xinglu Zhou

Medical Centers

  • Department of Lymphoma, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Cutaneous T-cell lymphoma

Biomarkers

  • Peripheral blood mononuclear cell

  • Signal Transducer And Activator Of Transcription 1

  • Signal Transducer And Activator Of Transcription 2

  • Signal transducer and activator of transcription 3

  • Signal Transducer And Activator Of Transcription 6

  • Interleukin 6

  • Janus kinase

  • Signal transducer and activator of transcription 4

Drug/Treatment

  • Ruxolitinib phosphate

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved